An official website of the United States government
07/27/2022: Lab Update: FDA Updates FAQs on Testing for SARS-CoV-2
Audience: Individuals Performing SARS-CoV-2 Testing
Level: Laboratory Update
On July 26, 2022, the U.S. Food and Drug Administration (FDA) updated its FAQs on Testing for SARS-CoV-2 page to note that no tests remain on the commercial manufacturer serology test notification list described in FDA’s Policy for Coronavirus Disease-2019 Tests. All tests previously on the commercial manufacturer serology test notification list have either been issued an Emergency Use Authorization (EUA) or should no longer be distributed, marketed, or offered.
Refer to the FDA Notifications and Emergency Use Authorizations: FAQs on Testing page for more information.
Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).
Online resources:
- Information for Laboratories about Coronavirus (COVID-19)
- Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories
- CDC Coronavirus (COVID-19) Website
- CDC Laboratory Outreach Communication System (LOCS)
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)